Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction

Biogerontology

Volumn 12, Issue 5, 2011, Pages 485-490

  Forte, Giusi Irma ^a   Vaccarino, Loredana ^a   Palmeri, Marisa ^a   Branzi, Angelo ^b   Caldarera, Claudio M ^b   Scola, Letizia ^a   Caruso, Calogero ^a   Licastro, Federico ^b   Lio, Domenico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Arterial thrombosis; Guidelines; Leiden Factor V; Prothrombin; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ACUTE HEART INFARCTION; ADULT; AGED; ALLELE; ARTERY THROMBOSIS; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENOTYPE; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROTHROMBIN;

EID: 83255187236     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-011-9358-z     Document Type: Conference Paper

References (26)

1. Billeci AM, Agnelli G, Caso V (2009) Stroke pharmacogenomics. Expert Opin Pharmacother 10(18):2947-2957
2. De Stefano V, Leone G (1995) Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia. Haematologica 80(4):344-356
3. De Stefano V, Finazzi G, Mannucci PM (1996) Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1 87(9):3531-3544 (Pubitemid 26129579)
4. Forte GI, Scola L, Vaccarino L, Sanacore M, Palmeri M, La Piana S, Pipitone M, Grimaudo S, Caruso C (2009) Analysis of FV-Leiden and Facor II G20210A SNP frequencies in a group of Sicilian nonagenarians. J Nutr Health Aging 13(1):S378
5. Franco RF, Trip MD, ten Cate H, van den Ende A, Prins MH, Kastelein JJ, Reitsma PH (1999) The 20210 G → A mutation in the 3' untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 104:50-54 (Pubitemid 29037017)
6. Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL (2001) Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis. Haemostasis 31(2):99-105 (Pubitemid 34701656)
7. Kahn M (2003) Hypercoagulability as a cause of stroke in adults. South Med J 96:350-353 (Pubitemid 37127519)
8. Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146(6):948-957 (Pubitemid 37500767)
9. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U (1996) Inherited thrombophilia. Thromb Haemost 76(5):651-662
10. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, Hoffmann E, Caruso M, Licastro F, Caldarera CM, Branzi A, Franceschi C, Caruso C (2004) Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41(10):790-794 (Pubitemid 39389298)
11. Listì F, Caruso M, Incalcaterra E, Hoffmann E, Caimi G, Balistreri CR, Vasto S, Scafidi V, Caruso C, Candore G (2008) Pro-inflammatory gene variants in myocardial infarction and longevity: implications for pharmacogenomics. Curr Pharm Des 14(26):2678-2685
12. Mari D, Coppola R, Provenzano R (2008) Hemostasis factors and aging. Exp Gerontol 43(2):66-73
13. Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L (2009) Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Blood Coagul Fibrinolysis 20(7):503-510
14. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 16:1215-1220
15. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD (1996) Increased activation of the hemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 75:767-771 (Pubitemid 26181548)
16. Ozmen F, Ozmen MM, Ozalp N, Akar N (2009) The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg 15(2):113-119
17. Peetz D, Schweigert R, Jachmann N, Post F, Schinzel H, Lackner KJ (2006) Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader. Clin Lab 52(11-12): 605-614 (Pubitemid 44883588)
18. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703 (Pubitemid 26383091)
19. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332(14):912-917
20. Ridker PM, Hennekens CH, Miletich JP (1999) G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 99(8):999-1004 (Pubitemid 29104487)
21. Russo C, Girelli D, Olivieri O, Guarini P, Manzato F, Pizzolo F, Zaia B, Mazzucco A, Corrocher R (2001) G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 103:2436-2440 (Pubitemid 32493368)
22. Soare AM, Popa C (2010) Deficiencies of proteins C, S and antithrombin and factor V Leiden and the risk of ischemic strokes. J Med Life 3(3):235-238
23. Testa S, Antonucci G, Intra E, Martini G, Pedrini S, Alatri A, Bader R, Manzato F (2004) Gli screening per trombofilia. Riv Med Lab-JLM 5(2):118
24. Tripodi A, Mannucci PM (2001) Laboratory investigation of thrombophilia. Clin Chem 47(9):1597-1606 (Pubitemid 32781572)
25. Van Cott E, Laposata M, Prins MH (2002) Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med 126:1281-1295
26. Soo L, Davidson P (2007) Laboratory testing for thrombophilia in arterial thrombosis. QML Pathology Medical PUB/MR/ 545, version 2